EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway

Bin Xiong, Junfeng Zhang, Yanmei Si, Jia Fu

Discover Oncology · 18.12.2024 · 15 (1)

DOI: 10.1007/s12672-024-01626-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 18.12.2024. Verfasst von Bin Xiong und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Jining Medical University, Jining City, 272067, Shandong Province, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China Youth Science Fund Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: A lack of effective delivery methods has hampered the study of therapeutics targeting miR-875-5p for breast cancer (BC). METHODS: The miR-875-5p mimic was conjugated to AuNPs to produce AuNP-miR-875-5p. Then, the effect of AuNP-miR-875-5p on the proliferative, migratory, invasive activities, and apoptosis of BC cells was detected, as well as on tumor growth in animals. The involvement of the MTDH/PTEN/AKT pathway in miR-875-5p-mediated BC progression was identified. RESULTS: AuNP-miR-875-5p was delivered to BC cells and hampered cell malignancy. MTDH was targeted by miR-875-5p. MTDH expression was negatively correlated with miR-875-5p expression in BC tissues. The anti-tumor effect of AuNP-miR-875-5p in BC cells was counteracted by MTDH overexpression. AuNP-miR-875-5p enhanced PTEN protein expression, thereby inhibiting AKT activation by targeting MTDH. AuNP-miR-875-5p blocked MCF-7 tumor growth in vivo. CONCLUSION: AuNPs can deliver miR-875-5p to BC cells, and AuNP-miR-875-5p has clinical potential for treating unresectable BC.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerGold nanoparticlesMTDHMiR-875-5pPTEN/Akt pathway

Autor:innen und Institutionen

  • School of Clinical Medicine, Jining Medical University, Jining City, 272067, Shandong Province, China.
  • School of Basic Medicine, Jining Medical University, No. 133 Hehua Road, Taibai Lake District, Jining City, 272067, Shandong Province, China.
  • School of Forensic Medicine and Laboratory Medicine, Jining Medical University, Jining City, 272067, Shandong Province, China. siyanmei90@hotmail.com.
  • School of Basic Medicine, Jining Medical University, No. 133 Hehua Road, Taibai Lake District, Jining City, 272067, Shandong Province, China. fj_fujiajining@outlook.com.

Förderung

  • National Natural Science Foundation of China Youth Science Fund Program

Zitieren

APA

Xiong, B., Zhang, J., Si, Y., & Fu, J. (2024). microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01626-5

Vancouver

Xiong B, Zhang J, Si Y, Fu J. microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01626-5

BibTeX
@article{Xiong2024,
  author = {Xiong, Bin and Zhang, Junfeng and Si, Yanmei and Fu, Jia},
  title = {microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01626-5}
}
Kostenlos starten →